Your browser doesn't support javascript.
loading
Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig®) in the treatment of patients with primary immunodeficiencies.
Kobayashi, Roger H; Litzman, Jirí; Melamed, Isaac; Mandujano, J Fernando; Kobayashi, Ai Lan; Ritchie, Bruce; Geng, Bob; Atkinson, T Prescott; Rehman, Syed; Höller, Sonja; Turpel-Kantor, Eva; Kreuwel, Huub; Speer, J C; Gupta, Sudhir.
Afiliação
  • Kobayashi RH; UCLA School of Medicine, Los Angeles, CA, USA.
  • Litzman J; Department of Clinical Immunology and Allergology, St Anne's University Hospital in Brno, Faculty of Medicine, Masaryk University, Brno, Czechia.
  • Melamed I; IMMUNOe Research Center, Centennial, CO, USA.
  • Mandujano JF; Pediatric Pulmonary Associates of North Texas, Frisco, TX, USA.
  • Kobayashi AL; Midlands Pediatrics, Papillion, NE, USA.
  • Ritchie B; Division of Hematology, Department of Medicine, University of Alberta Hospital, Edmonton, AB, Canada.
  • Geng B; Divisions of Allergy and Immunology, University of California San Diego, La Jolla, CA, USA.
  • Atkinson TP; Department of Pediatric Allergy, Asthma and Immunology, University of Alabama, Birmingham, AL, USA.
  • Rehman S; Allergy and Asthma Center Inc., Toledo, OH, USA.
  • Höller S; Octapharma Pharmazeutika Produktionsges.m.b.H., Vienna, Austria.
  • Turpel-Kantor E; Octapharma Pharmazeutika Produktionsges.m.b.H., Vienna, Austria.
  • Kreuwel H; Octapharma US, Paramus, NJ, USA.
  • Speer JC; Octapharma US, Paramus, NJ, USA.
  • Gupta S; Division of Basic and Clinical Immunology, University of California Irvine, Irvine, CA, USA.
Clin Exp Immunol ; 210(2): 91-103, 2022 12 15.
Article em En | MEDLINE | ID: mdl-36208448

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Bacterianas / Síndromes de Imunodeficiência Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Bacterianas / Síndromes de Imunodeficiência Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article